celecoxib has been researched along with Ovarian Hyperstimulation Syndrome in 1 studies
Ovarian Hyperstimulation Syndrome: A complication of OVULATION INDUCTION in infertility treatment. It is graded by the severity of symptoms which include OVARY enlargement, multiple OVARIAN FOLLICLES; OVARIAN CYSTS; ASCITES; and generalized EDEMA. The full-blown syndrome may lead to RENAL FAILURE, respiratory distress, and even DEATH. Increased capillary permeability is caused by the vasoactive substances, such as VASCULAR ENDOTHELIAL GROWTH FACTORS, secreted by the overly-stimulated OVARIES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study aimed to investigate the role of a cyclooxygenase inhibitor in ovarian hyperstimulation syndrome (OHSS) treatment and compare it with cabergoline." | 3.91 | Can a cyclooxygenase inhibitor be an option for treatment of ovarian hyperstimulation syndrome? ( Çilgin, H, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Çilgin, H | 1 |
1 other study available for celecoxib and Ovarian Hyperstimulation Syndrome
| Article | Year |
|---|---|
Can a cyclooxygenase inhibitor be an option for treatment of ovarian hyperstimulation syndrome?
Topics: Animals; Cabergoline; Celecoxib; Cyclooxygenase Inhibitors; Female; Injections, Subcutaneous; Ovaria | 2019 |